Rethinking Platelet and Plasma Transfusion Strategies for Neonates: Evidence, Guidelines, and Unanswered Questions
- 7 May 2025
- journal article
- review article
- Published by Georg Thieme Verlag KG in Seminars in Thrombosis and Hemostasis
- Vol. 52 (01) , 056-079
Abstract
The transfusion of platelets and fresh frozen plasma (FFP) to critically ill neonates in neonatal intensive care units (NICUs) is a common intervention, yet it is still widely performed without adhering to international guidelines. The guidance itself on the therapeutic management of neonatal coagulation disorders is generally limited due to the absence of strong indications for treatment and is mainly aimed at the prevention of major hemorrhagic events such as intraventricular hemorrhage (IVH) in premature neonates. Historically, the underrepresentation of neonates in clinical studies related to transfusion medicine had led to significant gaps in our knowledge regarding the best transfusion practices in this vulnerable group and to a wide variability in policies among different neonatal units, often based on local experience or guidance designed for older children or adults, and possibly increasing the risk of inappropriate or ineffective interventions. Platelet transfusion and, particularly, FFP administration have been linked to potentially fatal complications in neonates and thus any decision needs to be carefully balanced and requires a thorough consideration of multiple factors in the neonatal population. Despite recent advances toward more restrictive practices, platelet and FFP transfusions are still subject to wide variability in practices. This review examines the existing literature on platelet and FFP transfusions and on the management of massive hemorrhage in neonates, provides a summary of evidence-based guidelines on these topics, and highlights current developments and areas for ongoing and future research with the aim of improving clinical practices.Keywords
This publication has 137 references indexed in Scilit:
- Platelet Transfusion and Death or Neurodevelopmental Impairment in Children Born Extremely PretermJAMA Network Open, 2024
- Platelet transfusions in preterm infants: current concepts and controversies—a systematic review and meta-analysisEuropean Journal of Pediatrics, 2023
- Neonatal hematological parameters: the translational aspect of developmental hematopoiesisAnnals of Hematology, 2023
- Therapeutic use of Red Blood Cells and Platelets Derived from Human Cord Blood Stem CellsStem Cells Translational Medicine, 2021
- Association of Bleeding Scores and Platelet Transfusions With Platelet Counts and Closure Times in Response to Adenosine Diphosphate (CT-ADPs) Among Preterm Neonates With ThrombocytopeniaJAMA Network Open, 2020
- Platelet‐Activation Mechanisms and Vascular RemodelingComprehensive Physiology, 2018
- Thromboelastometry for diagnosis of neonatal sepsis-associated coagulopathy: an observational studyEuropean Journal of Pediatrics, 2017
- Transfusion of Plasma, Platelets, and Red Blood Cells in a 1:1:1 vs a 1:1:2 Ratio and Mortality in Patients With Severe TraumaJAMA, 2015
- Impact of ABO-Identical vs ABO-Compatible Nonidentical Plasma Transfusion in Trauma PatientsArchives of Surgery, 2010
- A randomized trial comparing the effect of prophylactic intravenous fresh frozen plasma, gelatin or glucose on early mortality and morbidity in preterm babiesEuropean Journal of Pediatrics, 1996